Back to Results
First PageMeta Content
Medical imaging / Radiation oncology / Radiopharmaceuticals / Positron emission tomography / Fludeoxyglucose / Molecular imaging / Single-photon emission computed tomography / Good manufacturing practice / Solitary pulmonary nodule / Medicine / Neuroimaging / Medical physics


Glucovision® 18 F-Fludeoxyglucose Injection (18F-FDG) Glucovision® is one of the most widely distributed molecular imaging agents in Ontario.
Add to Reading List

Document Date: 2011-11-30 14:32:57

Open Document

File Size: 649,38 KB

Share Result on Facebook

City

Hamilton / /

Company

CPDC / Rapid Response CPDC / /

Country

Canada / /

/

Facility

Commercialization McMaster University / Dana-Farber Cancer Institute / Nuclear Research Building / /

/

IndustryTerm

molecular imaging probes / molecular imaging agents / patient imaging procedures / manufacturing equipment / online product ordering portal / manufacturing / molecular imaging / /

MedicalCondition

cancer / Lymphoma / Colorectal cancer / sterility / small cell lung cancer / Germ cell tumours / pulmonary nodule / diseases / Non-small cell lung cancer / Thyroid cancer / /

Organization

Harvard Medical School / McMaster University / Boston Centre for Probe Development and Commercialization See / Ontario Ministry of Heath and Long-Term Care / Boston Centre for Probe Development / Dana-Farber Cancer Institute / Ministry of Health / /

Person

D. Van den Abbeele / /

/

Position

Governor / /

Product

F-Fludeoxyglucose Injection / /

ProvinceOrState

Ontario / /

Technology

tomography / /

URL

http /

SocialTag